MedPath

Prospective Evaluation of erectile function after Collagenase Therapy in Patietens with Peyronies Disease

Recruiting
Conditions
N48.6
Induratio penis plastica
Registration Number
DRKS00010450
Lead Sponsor
niversitätsklinik Freiburg, Abteilung für Urologie Sektion Andrologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
75
Inclusion Criteria

Patients with penile Peyronie´s Disease
stable disease for 6 Months
palpable penile Plaque
penile deviation (>30°)
collagenase therapy with Xiapex

Exclusion Criteria

Patients <18ys, missing consent to study, penile deviation of other causes, contraindications as listed by package insert

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of erectile function (IIEF and Peyronie questionaire),<br>decreased curvature (>30°)<br>Follow up 3, 6, 9, 12, 18, 24 months after therapy (IIEF and Peyronie questionaire)
Secondary Outcome Measures
NameTimeMethod
Quality of life<br>Sexual and erectile function (IIEF, PDQ questionaires)<br>Follow up 3,6,9,12,18,24 months after therapy
© Copyright 2025. All Rights Reserved by MedPath